ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation
Authors
Keywords
-
Journal
BLOOD
Volume 125, Issue 3, Pages 474-482
Publisher
American Society of Hematology
Online
2014-11-14
DOI
10.1182/blood-2014-04-572750
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress–induced assembly of PML nuclear bodies controls sumoylation of partner proteins
- (2014) Umut Sahin et al. JOURNAL OF CELL BIOLOGY
- PML nuclear bodies: regulation, function and therapeutic perspectives
- (2014) Umut Sahin et al. JOURNAL OF PATHOLOGY
- A Cellular System that Degrades Misfolded Proteins and Protects against Neurodegeneration
- (2014) Lili Guo et al. MOLECULAR CELL
- Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
- (2014) Julien Ablain et al. NATURE MEDICINE
- How I treat adult T-cell leukemia/lymphoma
- (2011) A. Bazarbachi et al. BLOOD
- The Sumo-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax
- (2011) K. A. Fryrear et al. BLOOD
- Molecular mechanisms of HTLV-1 infection and pathogenesis
- (2011) Junichiro Yasunaga et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?
- (2011) Rihab Nasr et al. Viruses-Basel
- Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome
- (2010) Y. Kfoury et al. BLOOD
- PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
- (2010) Marion Jeanne et al. CANCER CELL
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
- (2010) Hiba El Hajj et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Arsenic Trioxide Controls the Fate of the PML-RAR Oncoprotein by Directly Binding PML
- (2010) X. W. Zhang et al. SCIENCE
- PML Nuclear Bodies
- (2010) V. Lallemand-Breitenbach et al. Cold Spring Harbor Perspectives in Biology
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
- (2009) G. Kchour et al. BLOOD
- Curing APL: Differentiation or Destruction?
- (2009) Scott C. Kogan CANCER CELL
- Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation
- (2008) J. Arnold et al. BLOOD
- Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
- (2008) Kunihiro Tsukasaki et al. JOURNAL OF CLINICAL ONCOLOGY
- RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
- (2008) Michael H. Tatham et al. NATURE CELL BIOLOGY
- Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
- (2008) Valérie Lallemand-Breitenbach et al. NATURE CELL BIOLOGY
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now